Key Points
- Hinge Health Chairman Gabriel M.I. Mecklenburg sold 83,334 shares on June 1 at an average price of $60.22, totaling about $5.02 million. The sale was made under a pre-arranged Rule 10b5-1 trading plan and reduced his ownership by 50%.
- The chairman has been active in selling HNGE stock, including multiple earlier transactions in May, April, and March, with several sizable sales totaling millions of dollars. These trades suggest a continued pattern of insider selling.
- Hinge Health recently reported strong revenue growth and beat earnings expectations, posting $0.45 EPS versus the $0.12 consensus estimate on revenue of $182.31 million, up 47.2% year over year. Analysts remain broadly positive, with a consensus rating of “Moderate Buy” and an average target price of $67.40.
Hinge Health Inc. (NYSE:HNGE - Get Free Report) Chairman Gabriel M.I. Mecklenburg sold 83,334 shares of the firm's stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $60.22, for a total value of $5,018,373.48. Following the completion of the sale, the chairman directly owned 83,334 shares in the company, valued at $5,018,373.48. The trade was a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Gabriel M.I. Mecklenburg also recently made the following trade(s):
- On Tuesday, May 26th, Gabriel M.I. Mecklenburg sold 83,333 shares of Hinge Health stock. The stock was sold at an average price of $53.79, for a total value of $4,482,482.07.
- On Wednesday, May 6th, Gabriel M.I. Mecklenburg sold 50,000 shares of Hinge Health stock. The stock was sold at an average price of $55.01, for a total value of $2,750,500.00.
- On Tuesday, April 21st, Gabriel M.I. Mecklenburg sold 33,333 shares of Hinge Health stock. The stock was sold at an average price of $45.05, for a total transaction of $1,501,651.65.
- On Wednesday, April 1st, Gabriel M.I. Mecklenburg sold 50,000 shares of Hinge Health stock. The stock was sold at an average price of $38.46, for a total transaction of $1,923,000.00.
- On Friday, March 6th, Gabriel M.I. Mecklenburg sold 166,666 shares of Hinge Health stock. The stock was sold at an average price of $45.32, for a total transaction of $7,553,303.12.
Hinge Health Price Performance
Shares of HNGE opened at $58.62 on Thursday. Hinge Health Inc. has a one year low of $30.08 and a one year high of $62.18. The company has a 50-day simple moving average of $47.02 and a two-hundred day simple moving average of $45.03. The firm has a market capitalization of $4.54 billion and a PE ratio of -4.75.
Hinge Health (NYSE:HNGE - Get Free Report) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.12 by $0.33. Hinge Health had a negative net margin of 78.95% and a negative return on equity of 310.62%. The business had revenue of $182.31 million during the quarter. During the same quarter last year, the business earned $1.30 earnings per share. The business's quarterly revenue was up 47.2% on a year-over-year basis. Analysts expect that Hinge Health Inc. will post 1.21 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several research analysts recently weighed in on HNGE shares. Canaccord Genuity Group upped their target price on shares of Hinge Health from $53.00 to $63.00 and gave the stock a "buy" rating in a report on Wednesday, May 6th. Citizens Jmp increased their price objective on shares of Hinge Health from $65.00 to $80.00 and gave the company a "market outperform" rating in a report on Wednesday, May 6th. KeyCorp set a $55.00 price objective on shares of Hinge Health in a report on Wednesday, February 11th. Stifel Nicolaus increased their price objective on shares of Hinge Health from $59.00 to $67.00 and gave the company a "buy" rating in a report on Wednesday, May 6th. Finally, Wall Street Zen raised Hinge Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday, May 23rd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $67.40.
Check Out Our Latest Stock Report on HNGE
Hedge Funds Weigh In On Hinge Health
Institutional investors have recently modified their holdings of the stock. Wells Fargo & Company MN increased its position in shares of Hinge Health by 160.0% during the fourth quarter. Wells Fargo & Company MN now owns 546 shares of the company's stock worth $25,000 after acquiring an additional 336 shares during the period. Caitong International Asset Management Co. Ltd purchased a new position in Hinge Health during the fourth quarter valued at approximately $26,000. Mirae Asset Global Investments Co. Ltd. purchased a new position in Hinge Health during the third quarter valued at approximately $37,000. First Horizon Corp increased its holdings in Hinge Health by 163.9% during the fourth quarter. First Horizon Corp now owns 855 shares of the company's stock valued at $40,000 after buying an additional 531 shares during the period. Finally, CENTRAL TRUST Co purchased a new position in Hinge Health during the first quarter valued at approximately $37,000.
About Hinge Health
(
Get Free Report)
Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company's platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.
Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
